Porphyran Inhibits Osteoclast Formation Based on NF‐κB Signaling Pathways and Accelerates Alveolar Bone Healing in Ovariectomized Mice

Osteoporosis is characterized by a disrupted bone remodeling process, with bone resorption exceeding bone formation, resulting in reduced bone mass and impaired bone defect healing. Porphyran (PYP), a sulfated polysaccharide extracted from seaweed, inhibits osteoclast differentiation in vitro. This study aimed to explore the effects of PYP on osteoblasts and osteoclasts and on bone defect healing in ovariectomized (OVX) mice. In vitro, osteogenic and osteoclastic differentiation was assessed in PYP-treated MC3T3-E1 and BMMs using ALP staining, Alizarin Red staining, TRAP staining, immunofluorescence, qPCR, and western blotting. In vivo, 8-week-old female C57BL/6 mice underwent ovariectomy followed by right maxillary incisor extraction to establish osteoporotic bone defects. The mice were divided into Sham, OVX, and PYP (OVX with PYP treatment) groups. The PYP group received daily oral gavage of PYP (200 mg/kg), while the Sham and OVX groups received equivalent saline volumes. Extraction socket healing progression was assessed at 0, 7, and 21 days post-extraction using ELISA, qRT-PCR, µCT scanning, and histomorphometric analysis. The results showed that PYP did not enhance osteoblast differentiation but inhibited osteoclast differentiation by suppressing the NF-κB signaling pathway and promoted alveolar socket healing in OVX mice. In conclusion, porphyran promotes alveolar bone healing in osteoporotic mice by suppressing osteoclastogenesis via NF-κB signaling inhibition, suggesting its therapeutic potential for bone metabolic disorders. PRACTICAL APPLICATIONS: Porphyran (PYP), a natural seaweed compound, shows promise for creating bone-health supplements or dental recovery treatments. It helps reduce bone loss after procedures such as tooth extractions in osteoporosis patients while protecting the body's natural bone-building process. This plant-based solution could lead to safer clinical therapies for doctors and accessible natural products for people wanting stronger bones. Its gentle action makes it suitable for both medical use and everyday consumer health products.

Authors

Institutions

Publication Details

Journal
Journal of Food Science
Published
2025-09-01
DOI
https://doi.org/10.1111/1750-3841.70447
Primary Topic
Bone Metabolism and Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Porphyran Inhibits Osteoclast Formation Based on NF‐κB Signaling Pathways and Accelerates Alveolar Bone Healing in Ovariectomized Mice

Shao-peng Chu, Yiguo Zhao, Yuhua Wang, Yuqiong Wu et al.
2 links
Journal of Food Science
Bone Metabolism and Diseases
article

Porphyran Inhibits Osteoclast Formation Based on NF‐κB Signaling Pathways and Accelerates Alveolar Bone Healing in Ovariectomized Mice

Shao-peng Chu, Yiguo Zhao, Yuhua Wang, Yuqiong Wu, Zehua Duan
article en

Abstract

Osteoporosis is characterized by a disrupted bone remodeling process, with bone resorption exceeding bone formation, resulting in reduced bone mass and impaired bone defect healing. Porphyran (PYP), a sulfated polysaccharide extracted from seaweed, inhibits osteoclast differentiation in vitro. This study aimed to explore the effects of PYP on osteoblasts and osteoclasts and on bone defect healing in ovariectomized (OVX) mice. In vitro, osteogenic and osteoclastic differentiation was assessed in PYP-treated MC3T3-E1 and BMMs using ALP staining, Alizarin Red staining, TRAP staining, immunofluorescence, qPCR, and western blotting. In vivo, 8-week-old female C57BL/6 mice underwent ovariectomy followed by right maxillary incisor extraction to establish osteoporotic bone defects. The mice were divided into Sham, OVX, and PYP (OVX with PYP treatment) groups. The PYP group received daily oral gavage of PYP (200 mg/kg), while the Sham and OVX groups received equivalent saline volumes. Extraction socket healing progression was assessed at 0, 7, and 21 days post-extraction using ELISA, qRT-PCR, µCT scanning, and histomorphometric analysis. The results showed that PYP did not enhance osteoblast differentiation but inhibited osteoclast differentiation by suppressing the NF-κB signaling pathway and promoted alveolar socket healing in OVX mice. In conclusion, porphyran promotes alveolar bone healing in osteoporotic mice by suppressing osteoclastogenesis via NF-κB signaling inhibition, suggesting its therapeutic potential for bone metabolic disorders. PRACTICAL APPLICATIONS: Porphyran (PYP), a natural seaweed compound, shows promise for creating bone-health supplements or dental recovery treatments. It helps reduce bone loss after procedures such as tooth extractions in osteoporosis patients while protecting the body's natural bone-building process. This plant-based solution could lead to safer clinical therapies for doctors and accessible natural products for people wanting stronger bones. Its gentle action makes it suitable for both medical use and everyday consumer health products.

Journal of Food ScienceVol. 90(9)
Shanghai Jiao Tong University (CN), Shanghai Stomatological Hospital (CN), Shanghai Ninth People's Hospital (CN)
Openalex Percentile: Top 78%
Bone Metabolism and Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.